APG Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,300
Closed -$3.8M 548
2025
Q1
$3.8M Sell
27,300
-2,804
-9% -$470K 0.01% 477
2024
Q4
$5.37M Buy
30,104
+22,349
+288% +$4.31M 0.01% 452
2024
Q3
$1.37M Sell
7,755
-53,262
-87% -$11.1M 0.01% 346
2024
Q2
$11.8M Buy
61,017
+6,258
+11% +$1.42M 0.02% 389
2024
Q1
$13.7M Buy
54,759
+16,277
+42% +$3.89M 0.02% 389
2023
Q4
$8.24M Sell
38,482
-2,726
-7% -$536K 0.02% 425
2023
Q3
$8.08M Sell
41,208
-4,549
-10% -$934K 0.02% 432
2023
Q2
$8.82M Sell
45,757
-24
-0.1% -$4.78K 0.02% 425
2023
Q1
$8.5M Sell
45,781
-7,592
-14% -$1.72M 0.02% 440
2022
Q4
$11.6M Buy
53,373
+43,282
+429% +$9.45M 0.02% 432
2022
Q3
$2.03M Buy
10,091
+3,298
+49% +$712K 0.01% 546
2022
Q2
$1.39M Buy
6,793
+4,293
+172% +$1.05M ﹤0.01% 603
2022
Q1
$638K Sell
2,500
-100
-4% -$30.8K ﹤0.01% 777
2021
Q4
$861K Sell
2,600
-1,300
-33% -$505K ﹤0.01% 747
2021
Q3
$1.39M Sell
3,900
-1,900
-33% -$789K ﹤0.01% 686
2021
Q2
$1.81M Buy
+5,800
New +$1.94M ﹤0.01% 673
2018
Q3
Sell
-128,800
Closed -$12.4M 853
2018
Q2
$12.4M Sell
128,800
-138,800
-52% -$15M 0.02% 453
2018
Q1
$23.2M Sell
267,600
-101,200
-27% -$10.9M 0.04% 326
2017
Q4
$33.6M Buy
368,800
+266,700
+261% +$29M 0.06% 303
2017
Q3
$11M Buy
+102,100
New +$10.5M 0.02% 506

Other funds holding CRL

APG Asset Management's CRL Position: Q2 2025 in Review

APG Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 27,300 shares — an estimated $3.8M sold.

APG Asset Management first reported a position in CRL in Q3 2017 and held it in 20 quarters. The position peaked at $33.6M in Q4 2017. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • APG Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • APG Asset Management sold 27,300 Charles River Laboratories shares in Q2 2025, an estimated $3.8M.
  • APG Asset Management first reported a position in Charles River Laboratories in Q3 2017 and held it in 20 quarters.
  • APG Asset Management's Charles River Laboratories position peaked at $33.6M in Q4 2017.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on APG Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.